Generated with Avocode.Line 2Line 3
RapidAI Announces $75 Million Growth Investment
MUSC Revolutionizing Stroke and Aneurysm Care with RapidAI

RapidAI Aneurysm

Comprehensive Aneurysm Management

Rapid Aneurysm is an FDA-cleared imaging platform for cerebral aneurysm management. Helping physicians save time, improve patient care, and increase patient volume by accelerating the process of finding, tracking, and proactively treating aneurysms.

Find, track, treat

Revolutionize Aneurysm Surveillance and Treatment

Rapid Aneurysm is a one-of-a-kind comprehensive solution for the management of unruptured intracranial aneurysms, going far beyond simply notifying clinicians that a patient may have an aneurysm. Rapid Aneurysm provides 3D reconstructions of segmented intracranial arteries that empower clinicians to clearly visualize aneurysms. Rapid Aneurysm also provides clinically relevant aneurysm metrics and novel ways of measuring aneurysm size, surface area and volume to enhance aneurysm surveillance and treatment planning.

Converts 2D images to 3D vasculature models to aid in the visibility of aneurysms

Provides high-resolution measurement tools to help clinicians more precisely measure and visualize morphological changes


Improve patient care by finding and more accurately measuring aneurysms which may have gone undetected.


Save time using seamlessly converted 2D images to 3D vasculature models that accelerate the aneurysm workflow and help physicians make informed intervention decisions.


Increase patient volume and keep patients within your network for further imaging, tracking and treatment.

“A well-validated AI programme [Rapid Aneurysm] that detects cerebral aneurysms is expected to be an asset to radiologists. AI programmes that detect cerebral aneurysms on CTA have been shown to improve radiologists’ sensitivity for the detection of aneurysms.”

Dr. Jeremy Heit, MD
Interventional Neuroradiologist Stanford University

"Artificial intelligence aneurysm measurement tool [Rapid Aneurysm] finds growth in all aneurysms that ruptured during conservative management."

Daniel H. Sahlein MD
Director of Stroke at Ascension St. Vincent’s Indianapolis

Rapid Research Series

Volumetric AI-driven measurement represents the future of aneurysm management

Rapid Research Series

Imaging platform to visualize and find unruptured brain aneurysms in CTA scans


See the upside in time savings and revenue for your practice

Talk to an Expert